Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience.
Saved in:
| Title: | Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience. |
|---|---|
| Authors: | Reiner, Carolin M.1 (AUTHOR), Schneider, Martin A.2 (AUTHOR), Weilert, Hauke3,4 (AUTHOR), Welcker, Klara2,4 (AUTHOR), Hoedtke, Jochen5 (AUTHOR), Mahnken, Andreas H.6 (AUTHOR), Stang, Axel1,3,4 (AUTHOR) a.stang@asklepios.com, Brüning, Roland2 (AUTHOR) |
| Source: | Cancers. Dec2025, Vol. 17 Issue 23, p3834. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers17233834 |
